论文部分内容阅读
BACKGROUND: Pancreatic cancer is one of the most aggressive malignancies and chemotherapy is an effective strategy for advanced pancreatic cancer. Gemcitabine(GEM) is one of first-line agents. However, GEM-based combination therapy has shown promising eff